Robust Technology Change to Fuel the Global Prescription Narcotic Cough Preparations and Expectorants Market

Global Prescription Narcotic Cough Preparations and Expectorants Market

Narcotic preparations are medicines that primarily induce sleep. The three basic narcotics are morphine, codeine, and thebaine. Mucokinetics are drugs that clear mucus from the lungs, airways, trachea, and the bronchi. Mucokinetics are available in the forms of expectorants, mucolytic agents, and surfactants. Expectorants signal the body to amplify the quantity or hydration of secretions, thereby resulting in clearer secretions. As a by-product, the expectorant lubricates the respiratory tract. Guaifenesin, an expectorant is commonly used in many cough syrups. The term ‘expectorant’ is often extended to all cough medicines, as it is a universal constituent.

For More Information Request FREE Sample PDF Brochure: https://www.coherentmarketinsights.com/insight/request-sample/149

Cough is an abrupt and frequently occurring involuntary or voluntary reflex of the body in order to clear any unfamiliar material from the respiratory tract. Recurrent coughing is often associated with a variety of respiratory diseases, microbial infections, and chronic obstructive pulmonary diseases (COPD). Coughing is a communicable disease which gets transmitted through bacteria and viruses to the unaffected person. Cough medicines are medicines that are used during coughing and related conditions. Prescription narcotic cough preparations and expectorants are cough medicines that are narcotic in nature, and are supposed to be consumed only when prescribed by a physician.

Narcotic drugs, such as codeine, tussiden, hydrocodone, dihydrocodeine, hydromorphone, duraganidin, hydrostat, guaifenesin, and cheratussin, are some of the brands suggested for narcotic cough treatment. Narcotic drugs primarily target the nervous system and may have severe side effects. Therefore, these drugs are generally not prescribed to children below the age of 6 years. According to a report published in CNN Health in 2014, over 8 billion codeine prescriptions are issued in the U.S. each year. Narcotics may have side effects such as vomiting, rashes, allergy and constipation. Elevated occurrences of diseases and allergies will drive the future growth of the global prescription narcotic cough preparations and expectorants market.

Got any Query? Feel free to ask us at : https://www.coherentmarketinsights.com/insight/talk-to-analyst/149

Market Taxonomy

Based on the type of cough, the global prescription narcotic cough preparations and expectorants market is bifurcated into:

• • Acute cough
  • Chronic cough

The global prescription narcotic cough preparations and expectorants market comprises various end-use industries, including:

• • Government and Private Hospitals
  • Medical Practitioners
  • Others

As per a report published by the National Center for Biotechnology Information, acute cough falls under the top five complications of general practice. Acute cough or acute bronchitis is the fifth most frequent presentation in Australia and the U.S. Moreover, the report also suggests that in the U.K. almost 50 persons out of 100 suffer from acute cough. Moreover, acute cough results into to 10 ambulatory visits per 1000 patient, in the U.S. each year. Substantiation from general practice intelligence and the U.K. and U.S. morbidity surveys demonstrate that the cases of acute cough are increasing at an alarming rate. Therefore, the overall prescription narcotic cough preparations and expectorants market is expected to grow proportionately.

Apply Promo Code “STAYHOME” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/149

Rising incidences of pertussis to drive the overall prescription narcotic cough preparations and expectorants market growth

Pertussis or whooping cough is a respiratory disease which is highly contagious in nature. Uncontrollable and violent coughing can lead to death in extreme conditions. According to a 2014 report released by the Centers for Disease Control and Prevention, up to 32,971 cases of whooping cough were reported worldwide. This is a 15% increase as compared to the 28,639 cases reported in 2013. The increased rate of pertussis was observed mostly in the adolescents (13 to 15 years). Pertussis is a condition that needs physician’s advice for treatment, thereby increasing the demand for prescription narcotic cough treatment market. Moreover, babies are affected by cough and in some cases this might become fatal. Increased awareness, availability of advanced drugs, and adoption of early detection and prevention of diseases will accelerate the growth of the global prescription narcotic cough preparations and expectorants market.

Competitive Landscape

The leading manufacturers in the global market are Glenmark Pharmaceuticals Ltd., Franklin Laboratories Pvt. Ltd., Pans Laboratories, Synokem Pharmaceuticals Ltd., Lyka Hetero Healthcare Limited, Biomedica International, Klar Sehen Pvt. Ltd., and Ciron Drugs & Pharmaceuticals Pvt. Ltd. These market players compete on the basis of price, technology, and research & development activities.

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.